SCHEMBL3475951

SCHEMBL3475951

CC(Nc1cncc(Cl)n1)c1cccc(NC(=O)c2cccc(C(F)(F)F)c2)c1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 16/20 1.00
RET P07949 1/20 0.76
PDGFRB P09619 1/20 0.76
KIT P10721 1/20 0.76
SRC P12931 1/20 0.76
PDGFRA P16234 1/20 0.76
FLT1 P17948 1/20 0.76
FLT4 P35916 1/20 0.76
KDR P35968 1/20 0.76
FRK P42685 1/20 0.76
DDR1 Q08345 1/20 0.76
KCNQ3 O43525 2/20 0.53
KCNQ2 O43526 2/20 0.53
KCNE1 P15382 2/20 0.53
KCNQ1 P51787 2/20 0.53
KCNQ5 Q9NR82 1/20 0.52
MEN1 O00255 1/20 0.51
HTT P42858 1/20 0.51
RAB9A P51151 1/20 0.51
KMT2A Q03164 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3475948 1.00 CSF1R (1.00) CSF1RRETPDGFRBKITSRC
SCHEMBL13340366 1.00 CSF1R (1.00) CSF1RRETPDGFRBKITSRC
SCHEMBL13340255 0.94 CSF1R (0.88) CSF1RRETPDGFRBKITSRC
SCHEMBL18023962 0.93 CSF1R (0.86) CSF1RRETPDGFRBKITSRC
SCHEMBL13340264 0.90 CSF1R (0.82) CSF1RRETPDGFRBKITSRC
SCHEMBL14985459 0.90 CSF1R (0.82) CSF1RRETPDGFRBKITSRC
SCHEMBL13340224 0.90 CSF1R (0.82) CSF1RRETPDGFRBKITSRC
SCHEMBL3474629 0.89 CSF1R (0.81) CSF1RRETPDGFRBKITSRC
SCHEMBL3474631 0.89 CSF1R (0.81) CSF1RRETPDGFRBKITSRC
SCHEMBL13340265 0.89 CSF1R (0.81) CSF1RRETPDGFRBKITSRC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2848610-B1 Inhibitors of kinase activity YM BIOSCIENCES AUSTRALIA PTY (AU) 2017-10-11 EP disclosed
EP-3048099-A2 INHIBITORS OF KINASE ACTIVITY YM BioSciences Australia Pty Ltd (AU) 2016-07-27 EP disclosed
US-9029386-B2 Pyridine derivatives useful as kinase inhibitors GILEAD SCIENCES, INC. (US) 2015-05-12 US disclosed
EP-2848610-A1 Inhibitors of kinase activity YM BioSciences Australia Pty Ltd (AU) 2015-03-18 EP disclosed
US-8461161-B2 Substituted pyrazines as inhibitors of kinase activity YM BIOSCIENCES AUSTRALIA PTY LTD (AU) 2013-06-11 US disclosed
US-20130137660-A1 INHIBITORS OF KINASE ACTIVITY YM BIOSCIENCES AUSTRALIA PTY LTD (AU) 2013-05-30 US disclosed
US-20100130447-A1 INHIBITORS OF KINASE ACTIVITY YM BIOSCIENCES AUSTRALIA PTY LTD (AU) 2010-05-27 US disclosed
EP-2099774-A1 INHIBITORS OF KINASE ACTIVITY Cytopia Research Pty Ltd (AU) 2009-09-16 EP disclosed
WO-2008058341-A1 INHIBITORS OF KINASE ACTIVITY CYTOPIA RESEARCH PTY LTD (AU) 2008-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130137660-A1 INHIBITORS OF KINASE ACTIVITY FRK, LCK, FLT3 CSF1R 62/4885RET 4/4885PDGFRB 97/4885
US-20100130447-A1 INHIBITORS OF KINASE ACTIVITY FRK, LCK, FLT3 CSF1R 62/4885RET 4/4885PDGFRB 97/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.